Reumatische ziekten als risicofactoren voor hart- en vaatziekten

M. T. Nurmohamed; A. E. Voskuyl; I. E. Van Der Horst-Bruinsma; B. A.C. Dijkmans

Reumatische ziekten als risicofactoren voor hart- en vaatziekten

Translated title of the contribution: Rheumatic diseases as risk factors for cardiovascular disease

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

- Cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). In addition to mortality, cardiovascular morbidity is also markedly increased in these patients, compared with the general population. - The increased cardiovascular risk can be explained only partially by an increased prevalence of classical risk factors for cardiovascular disease; it also appears to be related to inflammation. - Prospective intervention trials aimed at the modification of cardiovascular risk factors are needed to determine the impact of cardiovascular risk reduction in patients with rheumatic disease. - In addition to SLE, RA and AS should be acknowledged as new risk factors for cardiovascular disease.

Translated title of the contribution	Rheumatic diseases as risk factors for cardiovascular disease
Original language	Dutch
Pages (from-to)	1921-1924
Number of pages	4
Journal	Nederlands tijdschrift voor geneeskunde
Volume	150
Issue number	35
Publication status	Published - 2 Sept 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{dc2e8bcc5b614be19c1159b5612ebf02,

title = "Reumatische ziekten als risicofactoren voor hart- en vaatziekten",

abstract = "- Cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). In addition to mortality, cardiovascular morbidity is also markedly increased in these patients, compared with the general population. - The increased cardiovascular risk can be explained only partially by an increased prevalence of classical risk factors for cardiovascular disease; it also appears to be related to inflammation. - Prospective intervention trials aimed at the modification of cardiovascular risk factors are needed to determine the impact of cardiovascular risk reduction in patients with rheumatic disease. - In addition to SLE, RA and AS should be acknowledged as new risk factors for cardiovascular disease.",

author = "Nurmohamed, \{M. T.\} and Voskuyl, \{A. E.\} and \{Van Der Horst-Bruinsma\}, \{I. E.\} and Dijkmans, \{B. A.C.\}",

year = "2006",

month = sep,

day = "2",

language = "Dutch",

volume = "150",

pages = "1921--1924",

journal = "Nederlands tijdschrift voor geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu Van Loghum",

number = "35",

}

TY - JOUR

T1 - Reumatische ziekten als risicofactoren voor hart- en vaatziekten

AU - Nurmohamed, M. T.

AU - Voskuyl, A. E.

AU - Van Der Horst-Bruinsma, I. E.

AU - Dijkmans, B. A.C.

PY - 2006/9/2

Y1 - 2006/9/2

N2 - - Cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). In addition to mortality, cardiovascular morbidity is also markedly increased in these patients, compared with the general population. - The increased cardiovascular risk can be explained only partially by an increased prevalence of classical risk factors for cardiovascular disease; it also appears to be related to inflammation. - Prospective intervention trials aimed at the modification of cardiovascular risk factors are needed to determine the impact of cardiovascular risk reduction in patients with rheumatic disease. - In addition to SLE, RA and AS should be acknowledged as new risk factors for cardiovascular disease.

AB - - Cardiovascular disease is the leading cause of death in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE). In addition to mortality, cardiovascular morbidity is also markedly increased in these patients, compared with the general population. - The increased cardiovascular risk can be explained only partially by an increased prevalence of classical risk factors for cardiovascular disease; it also appears to be related to inflammation. - Prospective intervention trials aimed at the modification of cardiovascular risk factors are needed to determine the impact of cardiovascular risk reduction in patients with rheumatic disease. - In addition to SLE, RA and AS should be acknowledged as new risk factors for cardiovascular disease.

UR - https://www.scopus.com/pages/publications/33749247401

M3 - Article

C2 - 16999275

AN - SCOPUS:33749247401

SN - 0028-2162

VL - 150

SP - 1921

EP - 1924

JO - Nederlands tijdschrift voor geneeskunde

JF - Nederlands tijdschrift voor geneeskunde

IS - 35

ER -

Reumatische ziekten als risicofactoren voor hart- en vaatziekten

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this